drugset / Trial / NCT06861439

GLP-1s to Enhance Lasting Optimal Weight

NCT06861439

Phase 4 Active not recruiting 40 enrolled Wake Forest University Health Sciences
NaSingle-groupOpen-labelTreatment

Summary

The goal of this study is to examine how tirzepatide affects body composition, bone health, and physical performance in older adults over a nine-month period. Participants will take tirzepatide weekly, have clinic visits every 4 weeks, meet study doctor and registered dietitian every 4 weeks in person or video conference, attend group intervention sessions twice a month via video conference, weigh daily with a study-provided smart scale, keep a record of all foods and beverages consumed, and use a study-provided activity tracker to keep track of daily step counts.

Timeline

Start
2025-07-07
Primary completion
2026-09-30
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Tirzepatide Peptide 5 mg

Indications